Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Outlook Therapeutics, Inc. | Director, 10%+ Owner | Common Stock | 5.81M | $2.44M | $0.42 | Mar 18, 2024 | Indirect |
Outlook Therapeutics, Inc. | Director, 10%+ Owner | Warrants (right to buy) | 3.46M | Mar 18, 2024 | Indirect |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
OTLK | Outlook Therapeutics, Inc. | Mar 18, 2024 | 2 | $0 | 4 | Mar 20, 2024 | Director, 10%+ Owner |
OTLK | Outlook Therapeutics, Inc. | Dec 28, 2022 | 1 | $12.5M | 4 | Dec 29, 2022 | Director, 10%+ Owner |
OTLK | Outlook Therapeutics, Inc. | Apr 21, 2022 | 1 | $0 | 4/A | Jul 7, 2022 | Director, 10%+ Owner |
OTLK | Outlook Therapeutics, Inc. | Feb 1, 2022 | 1 | $3.13M | 4 | Feb 1, 2022 | Director, 10%+ Owner |
OTLK | Outlook Therapeutics, Inc. | Nov 29, 2021 | 1 | $20M | 4 | Dec 1, 2021 | Director, 10%+ Owner |